Spain · AEMPS CIMA

VIRUS INFLUENZA GRIPE REASORTANTE,VIVO, ATENUADO, CEPA SIMILAR A B/ TOKYO/EIS13-175/2025

Source ingredient · 1 source records

Names are grouped within this source and country. A shared ingredient does not establish interchangeable medicines.

Spain · Source reference 1241816001

FLUENZ SUSPENSION PARA PULVERIZACION NASAL

SUSPENSIÓN PARA PULVERIZACIÓN NASAL / Astrazeneca Ab, Astrazeneca Farmaceutica Spain S.A.

Browse ingredients in Spain →
VIRUS INFLUENZA GRIPE REASORTANTE,VIVO, ATENUADO, CEPA SIMILAR A B/ TOKYO/EIS13-175/2025 | Molindra Medicines